"The Food and Drug Administration (FDA) is working to increase the participation of people in racial, ethnic and other minority groups in the clinical trials that test new medical products.
Why is this important?
Ensuring meaningful representation of minorities in clinical trials for regulated medical products is fundamental to FDA's regulatory mission and public health, says Jonca Bull, M.D., director of the agency's Office of Minority Health (OMH). Racial and ethnic minorities include African American, American Indian, Alaska Native, Asian American, Hispanic American, Native Hawaiian and Pacific Islander communities."
Read the rest of the article at: Clinical Trials Shed Light on Minority Health from FDA